中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
16期
105-107
,共3页
宫颈癌%化疗药物型栓塞剂%介入治疗
宮頸癌%化療藥物型栓塞劑%介入治療
궁경암%화료약물형전새제%개입치료
Cervical cancer%Type of embolic agent chemotherapy%Interventional chemotherapy
目的:探讨使用化疗药物型栓塞剂介入栓塞治疗宫颈癌的疗效及不良反应。方法对该院于2010年1月-2013年12月收治的150例宫颈癌患者进行子宫动脉介入栓塞化疗,随机分为治疗组和对照组,治疗组采用化疗药物型栓塞剂栓塞;对照组采用化疗药物动脉灌注后再行碘油乳剂栓塞,其后均用大颗粒明胶海绵栓塞。总结分析近期疗效、骨髓抑制反应及主要胃肠道反应。结果治疗组有效率为82.50%,对照组有效率为84.29%,差异无统计学意义(P>0.05)。但对照治疗后骨髓抑制反应及主要胃肠道反应两组差异明显。结论使用化疗药物型栓塞剂的患者治疗后不良反应明显小于对照组,患者易于接受,而疗效与对照组无明显差别。
目的:探討使用化療藥物型栓塞劑介入栓塞治療宮頸癌的療效及不良反應。方法對該院于2010年1月-2013年12月收治的150例宮頸癌患者進行子宮動脈介入栓塞化療,隨機分為治療組和對照組,治療組採用化療藥物型栓塞劑栓塞;對照組採用化療藥物動脈灌註後再行碘油乳劑栓塞,其後均用大顆粒明膠海綿栓塞。總結分析近期療效、骨髓抑製反應及主要胃腸道反應。結果治療組有效率為82.50%,對照組有效率為84.29%,差異無統計學意義(P>0.05)。但對照治療後骨髓抑製反應及主要胃腸道反應兩組差異明顯。結論使用化療藥物型栓塞劑的患者治療後不良反應明顯小于對照組,患者易于接受,而療效與對照組無明顯差彆。
목적:탐토사용화료약물형전새제개입전새치료궁경암적료효급불량반응。방법대해원우2010년1월-2013년12월수치적150례궁경암환자진행자궁동맥개입전새화료,수궤분위치료조화대조조,치료조채용화료약물형전새제전새;대조조채용화료약물동맥관주후재행전유유제전새,기후균용대과립명효해면전새。총결분석근기료효、골수억제반응급주요위장도반응。결과치료조유효솔위82.50%,대조조유효솔위84.29%,차이무통계학의의(P>0.05)。단대조치료후골수억제반응급주요위장도반응량조차이명현。결론사용화료약물형전새제적환자치료후불량반응명현소우대조조,환자역우접수,이료효여대조조무명현차별。
Objective To observe the efficacy and adverse reactions of interventional treatment with chemotherapy embolization a-gent for cervical cancer. Methods The 150 cases of cervical cancer patients with uterine artery embolization chemotherapy were randomly divided into treatment group and control group, the treatment group received chemotherapy embolization agent; the con-trol group arterial infusion chemotherapy after the line lipiodol emulsion embolization are subsequently gelfoam embolization with large particles. Summary analysis of short-term effect, bone marrow suppression response and major gastrointestinal reactions. Re-sults Efficiency of the control group, 82.50%, had no statistically significant difference with that, 84.29%, of the treatment group (P﹥0.05), but the bone marrow suppression and major gastrointestinal effects of the the two groups were significant differences. Conclusion Adverse reactions in patients after treatment of chemotherapy embolization agent is significantly less than that in the patients of the control group, so this method is easily accepted for patients, but there was no significant difference in the efficacy of the two groups.